Clinical Trials Directory

Trials / Unknown

UnknownNCT05373589

Effect of Pressure Support Ventilation During Anesthetic Emergence on Postoperative Atelectasis in Infant

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
136 (estimated)
Sponsor
Yonsei University · Academic / Other
Sex
All
Age
0 Years – 1 Year
Healthy volunteers
Accepted

Summary

Atelectasis occurs in patients of all ages who receive mechanical ventilation under general anesthesia, and although fatal cases are rare, it is known as a cause of postoperative hypoxia or fever. In pediatric patients, it has a particularly high incidence of 68-100%, and the incidence is inversely proportional to age. Pediatric patients,compared to adults, have a small capacity for functional residual capacity while a high metabolic demand, making them fundamentally vulnerable to hypoxia. Increased atelectasis during anesthesia causes hypoxia not only during anesthesia but also during recovery after anesthesia. Therefore, it is important to establish and apply a strategy to minimize the occurrence of atelectasis during mechanical ventilation under general anesthesia in pediatric patients. The aim of this study is to investigate whether pressure support ventilation at emergence period could reduce the incidence of postoperative atelectasis in infants undergoing surgery under general anesthesia.

Conditions

Interventions

TypeNameDescription
OTHERconventional ventilation, group CIn the conventional ventilation group, after stopping the administration of the inhalation gas, the emergence process is performed by the anesthesiologist assigned to the room. Basically, until spontaneous respiration of the patient is restored, an anesthesiologist can assist respiration by intermittent manual assistance if necessary.
OTHERpressure support, group PSIn the pressure support group, after stopping the administration of the inhalation gas, switch to the pressure support mode at the emergence period. PEEP 5cmH20 is applied, and the safety backup ventilation rate is set to 12 breaths/min. The flow trigger is set to 1L/min, and the degree of support is made to be 7-8ml of the predicted body weight, and is decreased as the patient's spontaneous breathing is restored.

Timeline

Start date
2022-05-01
Primary completion
2023-02-01
Completion
2023-02-01
First posted
2022-05-13
Last updated
2022-05-13

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT05373589. Inclusion in this directory is not an endorsement.